Report Description

Forecast Period


Market Size (2023)

USD 0.27 Billion

Market Size (2029)

USD 0.47 Billion

CAGR (2024-2029)


Fastest Growing Segment

Diagnostic Testing

Largest Market

Northern & Central


Market Overview

Saudi Arabia Genetic Testing Market was valued at USD 0.27 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 9.75% through 2029.  Genetic testing is a medical and diagnostic process that involves analyzing an individual's DNA, or genetic material, to uncover information about their genetic makeup, inheritance of specific traits, risk of certain diseases, and other genetic characteristics. This testing provides insights into an individual's genetic profile and can have various applications in healthcare, research, and personal decision-making. Genetic testing involves the analysis of an individual's DNA, which is composed of a unique sequence of nucleotide base pairs. This DNA sequence contains the instructions for building and functioning of the body. Before undergoing genetic testing, individuals often consult with genetic counselors who provide information about the testing process, potential outcomes, and the implications of test results. Genetic counseling helps individuals make informed decisions. Typically, a sample of DNA is collected for testing. This can be done through various means, including a blood sample, saliva, cheek swab, or tissue biopsy.

The surge in awareness regarding the pivotal role of genetic testing in disease prevention, early detection, and personalized treatment strategies serves as a catalyst for market expansion. This heightened awareness is largely propelled by targeted public health campaigns and educational initiatives, fostering a deeper understanding of the benefits of genetic testing among the populace. Moreover, notable advancements in genetic testing technologies, notably next-generation sequencing (NGS) and gene editing methodologies, have significantly enhanced the accessibility, affordability, and efficiency of genetic testing procedures. These technological strides not only streamline testing processes but also contribute to the market's growth trajectory by making genetic testing more feasible and practical for a broader demographic.

The escalating incidence of cancer, coupled with the imperative need for precision medicine approaches, underpins the growing demand for genetic testing within the oncology domain. The ability to ascertain cancer susceptibility and tailor treatment strategies based on individual genetic profiles emerges as a compelling driver propelling the adoption of genetic testing in oncological practices. Additionally, the rising significance of pharmacogenomic testing, which elucidates individual responses to medications based on genetic variations, is gaining prominence within the healthcare landscape. The advent of personalized medicine, fueled by insights from pharmacogenomics, emerges as a pivotal driver steering the integration of genetic testing into routine healthcare protocols.

Key Market Drivers

Increased Awareness About Genetic Testing

Awareness campaigns and educational efforts help individuals and families better understand their genetic risks. This understanding empowers them to make informed decisions about their healthcare, family planning, and disease prevention. Increased awareness encourages people to consider genetic testing to assess their risk of developing inherited diseases. Individuals become more proactive in taking steps to manage and reduce their risk based on genetic information. Genetic testing is seen as a valuable tool for preventive healthcare. When people are aware of the role genetics plays in health, they are more likely to seek out genetic testing to identify potential health risks early, leading to proactive measures. Couples who are aware of the possibility of genetic conditions in their families are more likely to consider genetic testing before having children. This can involve carrier testing to understand the risk of passing on genetic disorders to their offspring.

Expectant parents who are aware of the importance of genetic testing are more likely to opt for prenatal genetic testing to assess the health of their developing fetus. This awareness can lead to early intervention and treatment if necessary. Awareness of the role of genetics in cancer risk and the potential for targeted therapies drives demand for genetic testing in oncology. Patients and healthcare providers recognize the value of tailoring cancer treatments to an individual's genetic profile. Individuals become aware that their genetic makeup can influence how they respond to medications. As a result, there is an increased demand for pharmacogenomic testing to optimize medication choices and dosages.

Awareness campaigns and healthcare provider recommendations inform individuals about the benefits and limitations of genetic testing. Informed patients are more likely to make decisions that align with their healthcare goals. Greater awareness of the importance of assessing family medical history, which includes genetic factors, encourages individuals to explore genetic testing to better understand their inherited risk factors. Awareness efforts often focus on rare diseases and rare genetic variants. When individuals or families suspect they may be affected by such conditions, they are more likely to seek genetic testing for diagnosis and treatment options. Awareness is driven by advocacy groups, patient organizations, and healthcare professionals who promote the benefits of genetic testing. These advocates play a crucial role in disseminating information and fostering a culture of genetic health awareness. This factor will help in the development of the Saudi Arabia Genetic Testing Market.

Technological Advancements

 Next-Generation Sequencing (NGS) has revolutionized genetic testing by enabling the simultaneous sequencing of multiple genes and even entire genomes. This high-throughput technology has expanded the scope of genetic testing, allowing for comprehensive analysis of genetic variations associated with various diseases. Whole Genome Sequencing (WGS) involves sequencing an individual's entire genome. It provides a wealth of genetic information and is becoming increasingly accessible, enabling comprehensive genetic analysis for a wide range of conditions. Whole Exome Sequencing (WES) focuses on the protein-coding regions of genes, which are responsible for most disease-causing mutations. It offers a more cost-effective approach to identifying genetic variants associated with diseases. Advancements in pharmacogenomics enable the identification of genetic variations that affect an individual's response to medications. This personalized medicine approach is becoming more prominent in healthcare.

High-throughput technologies allow for the rapid analysis of multiple genetic markers or samples. This is particularly valuable for applications like population-wide screening and epidemiological studies. DNA microarrays are used for genotyping, gene expression analysis, and detecting chromosomal abnormalities. They have improved the efficiency of genetic testing for specific conditions. Digital PCR is a highly sensitive and precise technique for quantifying and characterizing nucleic acids. It has applications in the detection of genetic mutations and rare variants. Advanced bioinformatics tools and software have made it easier to process and interpret the vast amounts of genetic data generated through testing. These tools help in identifying relevant genetic variations associated with diseases. Liquid biopsies, including circulating tumor DNA (ctDNA) analysis, allow for non-invasive monitoring of genetic changes associated with cancer and other diseases. They have potential applications in early diagnosis and treatment monitoring.

Advances in miniaturized and portable genetic testing technologies have enabled point-of-care testing, which can be especially valuable in remote or underserved areas. AI and machine learning are being employed to analyze complex genetic data and identify patterns associated with disease risk, diagnosis, and treatment options. Ongoing advancements have led to cost reductions in genetic testing, making it more affordable and accessible to a broader population. Improvements in biobanking and sample management technologies ensure the preservation of genetic material for future research and testing. This factor will pace up the demand of the Saudi Arabia Genetic Testing Market.

Rise in Cancer Diagnostics

Genetic testing plays a crucial role in identifying individuals at higher risk of developing cancer due to inherited genetic mutations. This allows for early detection and preventive measures, such as increased surveillance or risk-reduction strategies. Genetic testing helps determine the genetic makeup of a patient's tumor, guiding the selection of targeted therapies. This approach, known as precision medicine, can improve treatment outcomes by tailoring interventions to the specific genetic characteristics of the cancer. Some families have a higher risk of developing specific types of cancer due to hereditary cancer syndromes. Genetic testing is essential for identifying individuals who carry these genetic mutations and may benefit from increased surveillance or risk-reduction strategies.

The increased focus on cancer diagnostics has led to a growing demand for genetic counseling. Genetic counselors help individuals understand their cancer risk and make informed decisions about genetic testing and preventive measures. Genetic testing for BRCA1 and BRCA2 mutations is especially relevant in breast and ovarian cancer risk assessment. With increased awareness of these mutations, more individuals seek genetic testing, especially if they have a family history of these cancers. Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers, can be identified through genetic testing. As colorectal cancer rates rise, the demand for genetic testing for Lynch syndrome increases. Genetic testing may identify hereditary factors contributing to pancreatic cancer risk. With the growing incidence of pancreatic cancer, there is an increased interest in identifying genetic predispositions.

Genetic testing for lung cancer helps determine specific genetic mutations that can inform treatment decisions, such as targeted therapies and immunotherapies. Many clinical trials in Saudi Arabia now incorporate genetic testing to identify eligible participants with specific genetic profiles for targeted cancer treatments. This drives the demand for genetic testing in the clinical research setting. Advocacy groups and healthcare organizations are working to raise awareness about the role of genetics in cancer risk and the importance of genetic testing. This increased awareness encourages individuals to seek testing. Ongoing research into the genetic underpinnings of cancer is leading to the identification of new genetic markers and potential therapeutic targets. This research fuels the demand for genetic testing in the field of oncology. This factor will accelerate the demand of the Saudi Arabia Genetic Testing Market.

Download Free Sample Report

Key Market Challenges

Data Privacy and Security

Genetic information is highly personal and sensitive. It can reveal not only an individual's health status but also information about their family members. Protecting the privacy of this data is crucial. The vast amount of genetic data generated through testing needs secure storage and management. This includes protecting data from unauthorized access and ensuring its integrity. Genetic data breaches can lead to identity theft, insurance discrimination, or other forms of exploitation. The consequences of data breaches involving genetic information can be severe. While there may be some regulatory framework in place, the evolving nature of genetic testing and data privacy challenges means that clear and comprehensive regulations are essential. Saudi Arabia may need to further refine its regulatory framework to address these issues. Patients must provide informed consent for genetic testing, understanding the implications for data privacy and security. Ensuring individuals fully comprehend what they are consenting to is a challenge. Collaborative research efforts and data sharing can be beneficial, but they also introduce potential privacy and security risks, especially if data is shared across borders.

Cultural and Religious Factors

Saudi Arabia has a conservative cultural and social environment, and privacy is highly valued. Sharing personal health information, especially genetic information, may be viewed with apprehension due to concerns about privacy and confidentiality. Islamic beliefs influence many aspects of life in Saudi Arabia, including healthcare decisions. Some individuals and families may have religious concerns about genetic testing, especially when it relates to prenatal testing, which can lead to ethical and religious dilemmas. Family is central in Saudi Arabian culture, and healthcare decisions often involve the family as a collective unit. Decisions about genetic testing may require consensus and may be influenced by family opinions. Concerns about potential stigma and discrimination may deter individuals from undergoing genetic testing. There may be a fear of social or familial repercussions if certain genetic conditions are discovered. Marriage is an important cultural and religious institution in Saudi Arabia. Genetic testing for hereditary conditions may be particularly relevant for couples planning to marry. However, the introduction of mandatory premarital genetic testing has faced mixed reactions in the past.

Key Market Trends

Increased Demand for Personalized Medicine

Genetic testing is being used to assess an individual's genetic predisposition to various diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders. This information can inform proactive health measures and early intervention. Pharmacogenomic testing is increasingly employed to determine how an individual's genetic makeup affects their response to medications. This allows for the selection of the most effective and safe medications for an individual, reducing the risk of adverse reactions. Genetic testing of cancerous tumors helps identify specific genetic mutations driving the cancer. This information is vital for selecting targeted therapies and predicting treatment outcomes. Genetic testing is used to diagnose and manage rare and inherited diseases. In Saudi Arabia, where certain genetic conditions are more prevalent, this is especially relevant. Couples and expectant parents are increasingly interested in genetic testing to assess the risk of passing on genetic disorders to their children, driving demand for preconception and prenatal genetic testing. Physicians are using genetic information to create customized treatment plans for patients, considering their unique genetic profiles. This can lead to more effective and personalized healthcare. Genetic testing can identify individuals at risk of developing certain diseases. This allows for preventive measures and early disease detection, potentially improving health outcomes.

Segmental Insights

Type Insights

In 2023, the Saudi Arabia Genetic Testing Market largest share was held by Diagnostic Testing segment and is predicted to continue expanding over the coming years. Diagnostic testing is at the core of genetic testing, as it is primarily used to detect and diagnose genetic disorders and diseases. It plays a crucial role in identifying various medical conditions, including inherited genetic diseases, genetic predispositions, and genetic variations associated with diseases. Genetic disorders, including inherited genetic conditions and genetic predispositions to diseases, are prevalent in populations worldwide, including Saudi Arabia. Diagnostic testing is essential for early disease detection and management. Saudi Arabia, like many countries, has established newborn screening programs that involve diagnostic genetic testing. These programs aim to identify and diagnose genetic and metabolic disorders in newborns, allowing for early intervention and treatment. The high prevalence of newborn screening contributes to the prominence of the Diagnostic Testing segment. Genetic counselling is often accompanied by diagnostic testing, helping individuals and families understand their genetic risks and make informed decisions about their healthcare and family planning. Diagnostic genetic testing is not only used for diagnosis but also for monitoring the progress and management of genetic disorders. Regular testing is important for patients with known genetic conditions to track their health status and response to treatments.

Technology Insights

In 2023, the Saudi Arabia Genetic Testing Market largest share was held by Biochemical Testing segment in the forecast period and is predicted to continue expanding over the coming years.  Biochemical testing is a broad category that encompasses a wide range of genetic tests, including metabolic and enzymatic assays, hormone tests, and tests for specific biochemical markers associated with genetic disorders. These tests play a critical role in diagnosing and monitoring various genetic and metabolic conditions, making them a fundamental component of genetic testing. Many countries, including Saudi Arabia, have implemented newborn screening programs that involve biochemical tests. These programs aim to detect and diagnose genetic and metabolic disorders in newborns, allowing for early intervention and treatment. The high prevalence of newborn screening contributes to the prominence of the Biochemical Testing segment. Biochemical testing is often used to diagnose common genetic disorders like phenylketonuria (PKU), congenital hypothyroidism, and galactosemia. These conditions require early detection and management, making biochemical testing an essential component of genetic healthcare. Biochemical tests are routinely performed in clinical practice, and they are often the first step in identifying potential genetic issues. As such, they have a broad application and are commonly used by healthcare professionals. Many genetic and metabolic disorders have well-established diagnostic protocols that involve biochemical testing. Physicians are trained to use these tests as part of their diagnostic toolkit.

Download Free Sample Report

Regional Insights

The Northern & Central region dominates the Saudi Arabia Genetic Testing Market in 2023. The Northern and Central regions of Saudi Arabia are home to major cities like Riyadh, Jeddah, and Dammam, which have well-established healthcare infrastructure and facilities. These regions typically have more advanced medical centers, hospitals, and laboratories equipped for genetic testing services. The Northern and Central regions have higher population densities compared to other parts of the country. This results in a larger pool of potential customers for genetic testing services, as well as a higher concentration of healthcare professionals and facilities. These regions are also the economic hubs of the country, with greater economic development and higher income levels. This makes genetic testing more accessible to individuals who can afford such services. Major universities, research institutions, and medical schools are often located in the Northern and Central regions. These institutions may conduct genetic research and offer genetic testing services, contributing to the growth of the market.

Recent Developments

  • In July 2023, Lifera and CENTOGENE have entered a strategic collaboration to form a joint venture (JV) in Saudi Arabia, aimed at enhancing access to leading data-driven multiomic testing. This JV combines CENTOGENE's global expertise in multiomics with Lifera's local insights as a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) in Riyadh. The partnership will offer state-of-the-art multiomic testing services to patients, health systems, biopharma clients, and research institutions across Saudi Arabia and the Gulf Cooperation Council (GCC) countries. CENTOGENE is currently one of the largest providers of genetic testing services in this market.

Key Market Players

  • Anwa Medical Labs
  • NoorDX
  • Scientific Laboratories Alliance Company Ltd.
  • ELAJ Group
  • Genetrack Saudi Arabia
  • Johnson & Johnson Services, Inc.
  • OncoDNA SA
  • Baylor Genetics-King Faisal Specialist Hospital — Saudi Diagnostic Limited


By Type

By Disease

By Technology

By Service Provider

By Region

  • Carrier Testing
  • Diagnostic Testing
  • New-born Screening
  • Predictive & Pre-symptomatic Testing
  • Prenatal Testing
  • Others
  • Sickle Cell Anemia
  • Thalassemia
  • Huntington's Disease
  • Cancer
  • Others
  • Cytogenetic Testing
  • Biochemical Testing
  • Molecular Testing
  • Clinical & Metabolic Specialists
  • Genetic Counsellors
  • Diagnostic Laboratories
  • Hospitals
  • Eastern
  • Western
  • Northern & Central
  • Southern


Report Scope:

In this report, the Saudi Arabia Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia Genetic Testing   Market, By Type:

o   Carrier Testing

o   Diagnostic Testing

o   New-born Screening

o   Predictive & Pre-symptomatic Testing

o   Prenatal Testing

o   Others

  • Saudi Arabia Genetic Testing   Market, By Disease:

o   Sickle Cell Anemia

o   Thalassemia

o   Huntington's Disease

o   Cancer

o   Others

  • Saudi Arabia Genetic Testing   Market, By Technology:

o   Cytogenetic Testing

o   Biochemical Testing

o   Molecular Testing

  • Saudi Arabia Genetic Testing   Market, By Service Providers:

o   Clinical & Metabolic Specialists

o   Genetic Counsellors

o   Diagnostic Laboratories

o   Hospitals

  • Saudi Arabia Genetic Testing Market, By region:

o   Eastern

o   Western

o   Northern & Central

o   Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Saudi Arabia Genetic Testing   Market.

Available Customizations:

Saudi Arabia Genetic Testing   Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Genetic Testing   Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Applications

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Saudi Arabia Genetic Testing Market Outlook

4.1.  Market Size & Forecast

4.1.1.     By Value

4.2.  Market Share & Forecast

4.2.1.        By Type (Carrier Testing, Diagnostic Testing, New-born Screening, Predictive & Pre-symptomatic Testing, Prenatal Testing, Others)

4.2.2.        By Disease (Sickle Cell Anemia, Thalassemia, Huntington's Disease, Cancer, Others)

4.2.3.        By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing)

4.2.4.        By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals)

4.2.5.     By Region (Eastern, Western, Northern & Central, Southern)

4.2.6.     By Company

4.3.  Product Market Map

5.    Saudi Arabia Cytogenetic Testing Market Outlook

5.1.  Market Size & Forecast       

5.1.1.By Value

5.2.  Market Share & Forecast

5.2.1.     By Type

5.2.2.     By Disease

5.2.3.     By Service Providers

6.    Saudi Arabia Biochemical Testing Market Outlook

6.1.  Market Size & Forecast       

6.1.1.By Value

6.2.  Market Share & Forecast

6.2.1.     By Type

6.2.2.     By Disease

6.2.3.     By Service Providers

7.    Saudi Arabia Molecular Testing Market Outlook

7.1.  Market Size & Forecast       

7.1.1.By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Disease

7.2.3.     By Service Providers

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

9.1.  Recent Developments

9.2.  Product Launches

9.3.  Mergers & Acquisitions

10. Policy & Regulatory Landscape

11. Saudi Arabia Economic Profile

12. Competitive Landscape

12.1.  Anwa Medical Labs

12.1.1.         Business Overview

12.1.2.         Product & Service Offerings

12.1.3.         Financials (If Listed)

12.1.4.         Recent Developments

12.1.5.         Key Personnel

12.1.6.         SWOT Analysis

12.2.  NoorDX

12.3.  Scientific Laboratories Alliance Company Ltd.

12.4.  ELAJ Group

12.5.  Genetrack Saudi Arabia

12.6.  Johnson & Johnson Services, Inc.

12.7.  OncoDNA SA

       12.8. Baylor Genetics-King Faisal Specialist Hospital — Saudi Diagnostic Limited

13. Strategic Recommendations

14. About us & Disclaimer

Figures and Tables

Frequently asked questions


The market size of the Genetic Testing Market was estimated to be USD 0.27 billion in 2023.


Anwa Medical Labs, NoorDX, Scientific Laboratories Alliance Company Ltd., ELAJ Group, Genetrack Saudi Arabia were some of the key players operating in the Genetic Testing Market.


Data Privacy and Security and Cultural and Religious Factors are the challenges faced by the Saudi Arabia Genetic Testing Market in the upcoming years.


Increased Awareness About Genetic Testing and Technological Advancement are the major drivers which drives the growth of the Saudi Arabia Genetic Testing Market.


Sakshi Bajaal

Business Consultant
Press Release

Saudi Arabia Genetic Testing Market to grow with a CAGR of 9.75% through 2029

May, 2024

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Saudi Arabia Genetic Testing Market during the forecast period, 2025-2029